News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,037 Results
Type
Article (14924)
Company Profile (301)
Press Release (266806)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (79927)
Career Advice (162)
Deals (13345)
Drug Delivery (40)
Drug Development (50789)
Employer Resources (32)
FDA (5849)
Job Trends (5173)
News (145284)
Policy (10085)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (921)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21791)
ALS (124)
Alzheimer's disease (1030)
Antibody-drug conjugate (ADC) (241)
Approvals (6043)
Artificial intelligence (259)
Autoimmune disease (110)
Automation (9)
Bankruptcy (105)
Best Places to Work (4565)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (355)
Cancer (3142)
Cardiovascular disease (237)
Career advice (147)
Career pathing (7)
CAR-T (217)
CDC (5)
Cell therapy (563)
Cervical cancer (14)
Clinical research (43743)
Collaboration (1149)
Company closure (2)
Compensation (591)
Complete response letters (39)
COVID-19 (1100)
CRISPR (86)
C-suite (550)
Cystic fibrosis (112)
Data (4326)
Denatured (15)
Depression (92)
Diabetes (254)
Diagnostics (1378)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (189)
Drug pricing (49)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (31665)
Editorial (25)
Employer branding (4)
Employer resources (30)
Events (51746)
Executive appointments (622)
FDA (7599)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (980)
Gene editing (182)
Generative AI (22)
Gene therapy (486)
GLP-1 (504)
Government (1149)
Grass and pollen (3)
Guidances (166)
Healthcare (6616)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (39)
Indications (66)
Infectious disease (1204)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (18)
IPO (7348)
IRA (13)
Job creations (868)
Job search strategy (129)
JPM (41)
Kidney cancer (9)
Labor market (22)
Layoffs (244)
Leadership (9)
Legal (1400)
Liver cancer (41)
Longevity (11)
Lung cancer (419)
Lymphoma (249)
Machine learning (24)
Management (8)
Manufacturing (376)
MASH (130)
Medical device (2666)
Medtech (2675)
Mergers & acquisitions (6620)
Metabolic disorders (724)
Multiple sclerosis (102)
NASH (13)
Neurodegenerative disease (230)
Neuropsychiatric disorders (70)
Neuroscience (1951)
Neurotech (1)
NextGen: Class of 2026 (2037)
Non-profit (865)
Now hiring (30)
Obesity (329)
Opinion (127)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (234)
Partnered (13)
Patents (301)
Patient recruitment (327)
Peanut (43)
People (26689)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15522)
Phase 2 (20293)
Phase 3 (12837)
Pipeline (3242)
Policy (91)
Postmarket research (861)
Preclinical (6551)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (648)
Real estate (1449)
Recruiting (12)
Regulatory (9905)
Reports (19)
Research institute (971)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (182)
Series B (135)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2007)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (333)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Last 7 days (345)
Last 30 days (1207)
Last 365 days (17827)
2026 (1653)
2025 (18129)
2024 (20567)
2023 (22437)
2022 (26857)
2021 (27838)
2020 (23387)
2019 (16244)
2018 (11759)
2017 (13767)
2016 (11868)
2015 (14378)
2014 (10412)
2013 (7504)
2012 (7547)
2011 (7642)
2010 (7449)
Location
Africa (155)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18295)
Australia (3113)
California (7074)
Canada (1837)
China (773)
Colorado (247)
Connecticut (282)
Delaware (235)
Europe (39225)
Florida (902)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (395)
India (35)
Indiana (162)
Iowa (8)
Japan (222)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (736)
Massachusetts (5580)
Michigan (110)
Minnesota (247)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1645)
New Mexico (13)
New York (1764)
North Carolina (825)
North Dakota (6)
Northern California (3473)
Ohio (177)
Oklahoma (11)
Oregon (24)
Pennsylvania (1277)
Puerto Rico (9)
Rhode Island (25)
South America (217)
South Carolina (9)
Southern California (2806)
Tennessee (40)
Texas (904)
United States (23358)
Utah (96)
Virginia (136)
Washington D.C. (37)
Washington State (592)
West Virginia (1)
Wisconsin (45)
282,037 Results for "prota therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Prota Therapeutics Announces PRT120 Follow-on Study Awarded EAACI Prize for Long-Term Post-Treatment Data Demonstrating Durable Remission Following 18 months of PRT120 Peanut Oral Immunotherapy
September 17, 2025
·
6 min read
Business
Prota Therapeutics’ CEO Mimi Tang honoured at BioMelbourne Network’s Women in Leadership Awards 2024
Prota Therapeutics ' CEO Professor Mimi Tang has been honoured in the prestigious 2024 BioMelbourne Network Women in Leadership Awards.
April 29, 2024
·
4 min read
Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments
Prota Therapeutics Pty Ltd today announced financing of US$21 million in equity and debt financing.
January 16, 2024
·
4 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Press Releases
Protara Therapeutics Highlights Recent Updates and Anticipated 2026 Milestones
January 12, 2026
·
8 min read
Press Releases
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 2, 2026
February 3, 2026
·
2 min read
Press Releases
Protara Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 7, 2026
·
1 min read
Drug Development
Global Roundup: Prota’s Immunotherapy Shows Success Against Peanut Allergy
In a Phase IIb study, data showed that Prota Therapeutics’ oral immunotherapy led to 51% of children reaching clinical remission of their peanut allergy compared to placebo. See inside for this and more!
May 18, 2022
·
8 min read
·
Alex Keown
Press Releases
Protagonist Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference 2026
January 7, 2026
·
2 min read
Press Releases
Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice
November 27, 2025
·
3 min read
1 of 28,204
Next
